nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimipramine—CYP2D6—Hydroxyurea—psoriasis	0.0493	0.0763	CbGbCtD
Trimipramine—CYP2C19—Cholecalciferol—psoriasis	0.0392	0.0608	CbGbCtD
Trimipramine—CYP3A4—Calcitriol—psoriasis	0.0368	0.0571	CbGbCtD
Trimipramine—CYP2C9—Cholecalciferol—psoriasis	0.0326	0.0506	CbGbCtD
Trimipramine—CYP2D6—Cholecalciferol—psoriasis	0.0298	0.0462	CbGbCtD
Trimipramine—CYP3A4—Methoxsalen—psoriasis	0.0286	0.0444	CbGbCtD
Trimipramine—ABCB1—Mycophenolate mofetil—psoriasis	0.0275	0.0426	CbGbCtD
Trimipramine—CYP2C19—Prednisone—psoriasis	0.0272	0.0422	CbGbCtD
Trimipramine—CYP2C19—Cyclosporine—psoriasis	0.0258	0.04	CbGbCtD
Trimipramine—ABCB1—Betamethasone—psoriasis	0.0236	0.0365	CbGbCtD
Trimipramine—ABCB1—Prednisolone—psoriasis	0.0232	0.036	CbGbCtD
Trimipramine—ABCB1—Hydrocortisone—psoriasis	0.022	0.0342	CbGbCtD
Trimipramine—ABCB1—Prednisone—psoriasis	0.022	0.034	CbGbCtD
Trimipramine—CYP2C9—Cyclosporine—psoriasis	0.0214	0.0332	CbGbCtD
Trimipramine—ABCB1—Cyclosporine—psoriasis	0.0208	0.0323	CbGbCtD
Trimipramine—CYP2D6—Cyclosporine—psoriasis	0.0196	0.0304	CbGbCtD
Trimipramine—CYP3A4—Cholecalciferol—psoriasis	0.019	0.0294	CbGbCtD
Trimipramine—CYP2C19—Dexamethasone—psoriasis	0.017	0.0263	CbGbCtD
Trimipramine—CYP3A4—Mycophenolate mofetil—psoriasis	0.0165	0.0255	CbGbCtD
Trimipramine—CYP3A4—Triamcinolone—psoriasis	0.0165	0.0255	CbGbCtD
Trimipramine—CYP2C9—Dexamethasone—psoriasis	0.0141	0.0219	CbGbCtD
Trimipramine—CYP3A4—Betamethasone—psoriasis	0.0141	0.0219	CbGbCtD
Trimipramine—CYP3A4—Prednisolone—psoriasis	0.0139	0.0216	CbGbCtD
Trimipramine—ABCB1—Dexamethasone—psoriasis	0.0137	0.0212	CbGbCtD
Trimipramine—CYP3A4—Hydrocortisone—psoriasis	0.0132	0.0205	CbGbCtD
Trimipramine—CYP3A4—Prednisone—psoriasis	0.0132	0.0204	CbGbCtD
Trimipramine—CYP2D6—Dexamethasone—psoriasis	0.0129	0.02	CbGbCtD
Trimipramine—CYP3A4—Cyclosporine—psoriasis	0.0125	0.0193	CbGbCtD
Trimipramine—ABCB1—Methotrexate—psoriasis	0.011	0.0171	CbGbCtD
Trimipramine—CYP3A4—Dexamethasone—psoriasis	0.00821	0.0127	CbGbCtD
Trimipramine—Arrhythmia—Betamethasone—psoriasis	0.000317	0.00103	CcSEcCtD
Trimipramine—Arrhythmia—Dexamethasone—psoriasis	0.000317	0.00103	CcSEcCtD
Trimipramine—Anorexia—Cyclosporine—psoriasis	0.000316	0.00103	CcSEcCtD
Trimipramine—Tachycardia—Mycophenolate mofetil—psoriasis	0.000316	0.00102	CcSEcCtD
Trimipramine—Ill-defined disorder—Triamcinolone—psoriasis	0.000316	0.00102	CcSEcCtD
Trimipramine—Alopecia—Dexamethasone—psoriasis	0.000313	0.00102	CcSEcCtD
Trimipramine—Alopecia—Betamethasone—psoriasis	0.000313	0.00102	CcSEcCtD
Trimipramine—Convulsion—Hydrocortisone—psoriasis	0.000313	0.00102	CcSEcCtD
Trimipramine—Hypertension—Hydrocortisone—psoriasis	0.000312	0.00101	CcSEcCtD
Trimipramine—Vomiting—Hydroxyurea—psoriasis	0.000311	0.00101	CcSEcCtD
Trimipramine—Discomfort—Prednisolone—psoriasis	0.000311	0.00101	CcSEcCtD
Trimipramine—Rash—Hydroxyurea—psoriasis	0.000309	0.001	CcSEcCtD
Trimipramine—Anorexia—Mycophenolate mofetil—psoriasis	0.000308	0.001	CcSEcCtD
Trimipramine—Dermatitis—Hydroxyurea—psoriasis	0.000308	0.001	CcSEcCtD
Trimipramine—Hallucination—Prednisone—psoriasis	0.000307	0.000997	CcSEcCtD
Trimipramine—Malaise—Triamcinolone—psoriasis	0.000307	0.000995	CcSEcCtD
Trimipramine—Headache—Hydroxyurea—psoriasis	0.000307	0.000995	CcSEcCtD
Trimipramine—Anxiety—Hydrocortisone—psoriasis	0.000306	0.000994	CcSEcCtD
Trimipramine—Pancytopenia—Methotrexate—psoriasis	0.000306	0.000993	CcSEcCtD
Trimipramine—Discomfort—Hydrocortisone—psoriasis	0.000304	0.000986	CcSEcCtD
Trimipramine—Hypotension—Mycophenolate mofetil—psoriasis	0.000302	0.000981	CcSEcCtD
Trimipramine—Oedema—Prednisolone—psoriasis	0.000302	0.000979	CcSEcCtD
Trimipramine—Insomnia—Cyclosporine—psoriasis	0.0003	0.000973	CcSEcCtD
Trimipramine—Paraesthesia—Cyclosporine—psoriasis	0.000298	0.000966	CcSEcCtD
Trimipramine—Erectile dysfunction—Methotrexate—psoriasis	0.000297	0.000963	CcSEcCtD
Trimipramine—Somnolence—Cyclosporine—psoriasis	0.000295	0.000957	CcSEcCtD
Trimipramine—Oedema—Hydrocortisone—psoriasis	0.000295	0.000956	CcSEcCtD
Trimipramine—Convulsion—Triamcinolone—psoriasis	0.000295	0.000956	CcSEcCtD
Trimipramine—Tachycardia—Prednisolone—psoriasis	0.000295	0.000956	CcSEcCtD
Trimipramine—Asthenia—Mycophenolic acid—psoriasis	0.000294	0.000954	CcSEcCtD
Trimipramine—Hypertension—Triamcinolone—psoriasis	0.000294	0.000953	CcSEcCtD
Trimipramine—Insomnia—Mycophenolate mofetil—psoriasis	0.000293	0.00095	CcSEcCtD
Trimipramine—Dyspepsia—Cyclosporine—psoriasis	0.000292	0.000947	CcSEcCtD
Trimipramine—Nausea—Hydroxyurea—psoriasis	0.000291	0.000943	CcSEcCtD
Trimipramine—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000291	0.000943	CcSEcCtD
Trimipramine—Pruritus—Mycophenolic acid—psoriasis	0.00029	0.000941	CcSEcCtD
Trimipramine—Decreased appetite—Cyclosporine—psoriasis	0.000288	0.000936	CcSEcCtD
Trimipramine—Tachycardia—Hydrocortisone—psoriasis	0.000288	0.000933	CcSEcCtD
Trimipramine—Somnolence—Mycophenolate mofetil—psoriasis	0.000288	0.000933	CcSEcCtD
Trimipramine—Drowsiness—Methotrexate—psoriasis	0.000287	0.000932	CcSEcCtD
Trimipramine—Flushing—Prednisone—psoriasis	0.000286	0.00093	CcSEcCtD
Trimipramine—Ill-defined disorder—Dexamethasone—psoriasis	0.000286	0.000929	CcSEcCtD
Trimipramine—Ill-defined disorder—Betamethasone—psoriasis	0.000286	0.000929	CcSEcCtD
Trimipramine—Discomfort—Triamcinolone—psoriasis	0.000286	0.000928	CcSEcCtD
Trimipramine—Fatigue—Cyclosporine—psoriasis	0.000286	0.000928	CcSEcCtD
Trimipramine—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000285	0.000924	CcSEcCtD
Trimipramine—Constipation—Cyclosporine—psoriasis	0.000284	0.00092	CcSEcCtD
Trimipramine—Dry mouth—Triamcinolone—psoriasis	0.000283	0.000919	CcSEcCtD
Trimipramine—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000281	0.000913	CcSEcCtD
Trimipramine—Anorexia—Hydrocortisone—psoriasis	0.000281	0.000912	CcSEcCtD
Trimipramine—Diarrhoea—Mycophenolic acid—psoriasis	0.00028	0.00091	CcSEcCtD
Trimipramine—Stomatitis—Methotrexate—psoriasis	0.00028	0.000909	CcSEcCtD
Trimipramine—Malaise—Betamethasone—psoriasis	0.000278	0.000903	CcSEcCtD
Trimipramine—Malaise—Dexamethasone—psoriasis	0.000278	0.000903	CcSEcCtD
Trimipramine—Oedema—Triamcinolone—psoriasis	0.000278	0.000901	CcSEcCtD
Trimipramine—Constipation—Mycophenolate mofetil—psoriasis	0.000277	0.000898	CcSEcCtD
Trimipramine—Arrhythmia—Prednisone—psoriasis	0.000276	0.000895	CcSEcCtD
Trimipramine—Hypotension—Hydrocortisone—psoriasis	0.000275	0.000894	CcSEcCtD
Trimipramine—Feeling abnormal—Cyclosporine—psoriasis	0.000273	0.000887	CcSEcCtD
Trimipramine—Insomnia—Prednisolone—psoriasis	0.000273	0.000886	CcSEcCtD
Trimipramine—Alopecia—Prednisone—psoriasis	0.000273	0.000885	CcSEcCtD
Trimipramine—Dizziness—Mycophenolic acid—psoriasis	0.000271	0.00088	CcSEcCtD
Trimipramine—Paraesthesia—Prednisolone—psoriasis	0.000271	0.000879	CcSEcCtD
Trimipramine—Tachycardia—Triamcinolone—psoriasis	0.000271	0.000879	CcSEcCtD
Trimipramine—Agranulocytosis—Methotrexate—psoriasis	0.000268	0.00087	CcSEcCtD
Trimipramine—Convulsion—Dexamethasone—psoriasis	0.000267	0.000867	CcSEcCtD
Trimipramine—Convulsion—Betamethasone—psoriasis	0.000267	0.000867	CcSEcCtD
Trimipramine—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000267	0.000865	CcSEcCtD
Trimipramine—Insomnia—Hydrocortisone—psoriasis	0.000267	0.000865	CcSEcCtD
Trimipramine—Hypertension—Dexamethasone—psoriasis	0.000266	0.000864	CcSEcCtD
Trimipramine—Hypertension—Betamethasone—psoriasis	0.000266	0.000864	CcSEcCtD
Trimipramine—Paraesthesia—Hydrocortisone—psoriasis	0.000265	0.000859	CcSEcCtD
Trimipramine—Urticaria—Cyclosporine—psoriasis	0.000263	0.000855	CcSEcCtD
Trimipramine—Abdominal pain—Cyclosporine—psoriasis	0.000262	0.000851	CcSEcCtD
Trimipramine—Body temperature increased—Cyclosporine—psoriasis	0.000262	0.000851	CcSEcCtD
Trimipramine—Anxiety—Betamethasone—psoriasis	0.000262	0.000849	CcSEcCtD
Trimipramine—Anxiety—Dexamethasone—psoriasis	0.000262	0.000849	CcSEcCtD
Trimipramine—Vomiting—Mycophenolic acid—psoriasis	0.000261	0.000846	CcSEcCtD
Trimipramine—Discomfort—Dexamethasone—psoriasis	0.00026	0.000842	CcSEcCtD
Trimipramine—Discomfort—Betamethasone—psoriasis	0.00026	0.000842	CcSEcCtD
Trimipramine—Dyspepsia—Hydrocortisone—psoriasis	0.000259	0.000842	CcSEcCtD
Trimipramine—Rash—Mycophenolic acid—psoriasis	0.000258	0.000839	CcSEcCtD
Trimipramine—Dermatitis—Mycophenolic acid—psoriasis	0.000258	0.000838	CcSEcCtD
Trimipramine—Urticaria—Mycophenolate mofetil—psoriasis	0.000257	0.000834	CcSEcCtD
Trimipramine—Headache—Mycophenolic acid—psoriasis	0.000257	0.000833	CcSEcCtD
Trimipramine—Decreased appetite—Hydrocortisone—psoriasis	0.000256	0.000831	CcSEcCtD
Trimipramine—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000256	0.00083	CcSEcCtD
Trimipramine—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000256	0.00083	CcSEcCtD
Trimipramine—Fatigue—Hydrocortisone—psoriasis	0.000254	0.000825	CcSEcCtD
Trimipramine—Vision blurred—Prednisone—psoriasis	0.000253	0.000822	CcSEcCtD
Trimipramine—Oedema—Dexamethasone—psoriasis	0.000252	0.000817	CcSEcCtD
Trimipramine—Oedema—Betamethasone—psoriasis	0.000252	0.000817	CcSEcCtD
Trimipramine—Insomnia—Triamcinolone—psoriasis	0.000251	0.000815	CcSEcCtD
Trimipramine—Ill-defined disorder—Prednisone—psoriasis	0.000249	0.000809	CcSEcCtD
Trimipramine—Paraesthesia—Triamcinolone—psoriasis	0.000249	0.000809	CcSEcCtD
Trimipramine—Feeling abnormal—Prednisolone—psoriasis	0.000249	0.000807	CcSEcCtD
Trimipramine—Agitation—Prednisone—psoriasis	0.000247	0.000801	CcSEcCtD
Trimipramine—Thrombocytopenia—Dexamethasone—psoriasis	0.000247	0.0008	CcSEcCtD
Trimipramine—Thrombocytopenia—Betamethasone—psoriasis	0.000247	0.0008	CcSEcCtD
Trimipramine—Tachycardia—Dexamethasone—psoriasis	0.000246	0.000798	CcSEcCtD
Trimipramine—Tachycardia—Betamethasone—psoriasis	0.000246	0.000798	CcSEcCtD
Trimipramine—Dyspepsia—Triamcinolone—psoriasis	0.000244	0.000793	CcSEcCtD
Trimipramine—Nausea—Mycophenolic acid—psoriasis	0.000244	0.00079	CcSEcCtD
Trimipramine—Feeling abnormal—Hydrocortisone—psoriasis	0.000243	0.000788	CcSEcCtD
Trimipramine—Malaise—Prednisone—psoriasis	0.000242	0.000786	CcSEcCtD
Trimipramine—Tinnitus—Methotrexate—psoriasis	0.000241	0.00078	CcSEcCtD
Trimipramine—Anorexia—Dexamethasone—psoriasis	0.00024	0.000779	CcSEcCtD
Trimipramine—Anorexia—Betamethasone—psoriasis	0.00024	0.000779	CcSEcCtD
Trimipramine—Urticaria—Prednisolone—psoriasis	0.00024	0.000778	CcSEcCtD
Trimipramine—Fatigue—Triamcinolone—psoriasis	0.000239	0.000776	CcSEcCtD
Trimipramine—Asthenia—Cyclosporine—psoriasis	0.000238	0.000772	CcSEcCtD
Trimipramine—Hypotension—Betamethasone—psoriasis	0.000235	0.000764	CcSEcCtD
Trimipramine—Hypotension—Dexamethasone—psoriasis	0.000235	0.000764	CcSEcCtD
Trimipramine—Pruritus—Cyclosporine—psoriasis	0.000235	0.000761	CcSEcCtD
Trimipramine—Urticaria—Hydrocortisone—psoriasis	0.000234	0.00076	CcSEcCtD
Trimipramine—Body temperature increased—Hydrocortisone—psoriasis	0.000233	0.000756	CcSEcCtD
Trimipramine—Abdominal pain—Hydrocortisone—psoriasis	0.000233	0.000756	CcSEcCtD
Trimipramine—Convulsion—Prednisone—psoriasis	0.000233	0.000755	CcSEcCtD
Trimipramine—Asthenia—Mycophenolate mofetil—psoriasis	0.000232	0.000753	CcSEcCtD
Trimipramine—Hypertension—Prednisone—psoriasis	0.000232	0.000753	CcSEcCtD
Trimipramine—Pruritus—Mycophenolate mofetil—psoriasis	0.000229	0.000743	CcSEcCtD
Trimipramine—Feeling abnormal—Triamcinolone—psoriasis	0.000229	0.000742	CcSEcCtD
Trimipramine—Anxiety—Prednisone—psoriasis	0.000228	0.00074	CcSEcCtD
Trimipramine—Alopecia—Methotrexate—psoriasis	0.000228	0.00074	CcSEcCtD
Trimipramine—Insomnia—Dexamethasone—psoriasis	0.000228	0.000739	CcSEcCtD
Trimipramine—Insomnia—Betamethasone—psoriasis	0.000228	0.000739	CcSEcCtD
Trimipramine—Diarrhoea—Cyclosporine—psoriasis	0.000227	0.000736	CcSEcCtD
Trimipramine—Paraesthesia—Betamethasone—psoriasis	0.000226	0.000734	CcSEcCtD
Trimipramine—Paraesthesia—Dexamethasone—psoriasis	0.000226	0.000734	CcSEcCtD
Trimipramine—Discomfort—Prednisone—psoriasis	0.000226	0.000733	CcSEcCtD
Trimipramine—Dyspepsia—Dexamethasone—psoriasis	0.000222	0.000719	CcSEcCtD
Trimipramine—Dyspepsia—Betamethasone—psoriasis	0.000222	0.000719	CcSEcCtD
Trimipramine—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000221	0.000718	CcSEcCtD
Trimipramine—Urticaria—Triamcinolone—psoriasis	0.00022	0.000715	CcSEcCtD
Trimipramine—Dysgeusia—Methotrexate—psoriasis	0.00022	0.000714	CcSEcCtD
Trimipramine—Body temperature increased—Triamcinolone—psoriasis	0.000219	0.000712	CcSEcCtD
Trimipramine—Dizziness—Cyclosporine—psoriasis	0.000219	0.000712	CcSEcCtD
Trimipramine—Oedema—Prednisone—psoriasis	0.000219	0.000712	CcSEcCtD
Trimipramine—Decreased appetite—Dexamethasone—psoriasis	0.000219	0.00071	CcSEcCtD
Trimipramine—Decreased appetite—Betamethasone—psoriasis	0.000219	0.00071	CcSEcCtD
Trimipramine—Fatigue—Betamethasone—psoriasis	0.000217	0.000704	CcSEcCtD
Trimipramine—Fatigue—Dexamethasone—psoriasis	0.000217	0.000704	CcSEcCtD
Trimipramine—Tachycardia—Prednisone—psoriasis	0.000214	0.000695	CcSEcCtD
Trimipramine—Dizziness—Mycophenolate mofetil—psoriasis	0.000214	0.000694	CcSEcCtD
Trimipramine—Vision blurred—Methotrexate—psoriasis	0.000212	0.000687	CcSEcCtD
Trimipramine—Asthenia—Hydrocortisone—psoriasis	0.000211	0.000686	CcSEcCtD
Trimipramine—Vomiting—Cyclosporine—psoriasis	0.000211	0.000684	CcSEcCtD
Trimipramine—Rash—Cyclosporine—psoriasis	0.000209	0.000679	CcSEcCtD
Trimipramine—Anorexia—Prednisone—psoriasis	0.000209	0.000678	CcSEcCtD
Trimipramine—Dermatitis—Cyclosporine—psoriasis	0.000209	0.000678	CcSEcCtD
Trimipramine—Pruritus—Hydrocortisone—psoriasis	0.000209	0.000677	CcSEcCtD
Trimipramine—Ill-defined disorder—Methotrexate—psoriasis	0.000208	0.000676	CcSEcCtD
Trimipramine—Headache—Cyclosporine—psoriasis	0.000208	0.000674	CcSEcCtD
Trimipramine—Feeling abnormal—Dexamethasone—psoriasis	0.000208	0.000673	CcSEcCtD
Trimipramine—Feeling abnormal—Betamethasone—psoriasis	0.000208	0.000673	CcSEcCtD
Trimipramine—Vomiting—Mycophenolate mofetil—psoriasis	0.000206	0.000667	CcSEcCtD
Trimipramine—Rash—Mycophenolate mofetil—psoriasis	0.000204	0.000662	CcSEcCtD
Trimipramine—Dermatitis—Mycophenolate mofetil—psoriasis	0.000204	0.000661	CcSEcCtD
Trimipramine—Headache—Mycophenolate mofetil—psoriasis	0.000203	0.000658	CcSEcCtD
Trimipramine—Malaise—Methotrexate—psoriasis	0.000203	0.000657	CcSEcCtD
Trimipramine—Diarrhoea—Hydrocortisone—psoriasis	0.000202	0.000654	CcSEcCtD
Trimipramine—Urticaria—Betamethasone—psoriasis	0.0002	0.000649	CcSEcCtD
Trimipramine—Urticaria—Dexamethasone—psoriasis	0.0002	0.000649	CcSEcCtD
Trimipramine—Dizziness—Prednisolone—psoriasis	0.0002	0.000648	CcSEcCtD
Trimipramine—Asthenia—Triamcinolone—psoriasis	0.000199	0.000646	CcSEcCtD
Trimipramine—Abdominal pain—Betamethasone—psoriasis	0.000199	0.000646	CcSEcCtD
Trimipramine—Body temperature increased—Dexamethasone—psoriasis	0.000199	0.000646	CcSEcCtD
Trimipramine—Abdominal pain—Dexamethasone—psoriasis	0.000199	0.000646	CcSEcCtD
Trimipramine—Body temperature increased—Betamethasone—psoriasis	0.000199	0.000646	CcSEcCtD
Trimipramine—Insomnia—Prednisone—psoriasis	0.000198	0.000644	CcSEcCtD
Trimipramine—Nausea—Cyclosporine—psoriasis	0.000197	0.000639	CcSEcCtD
Trimipramine—Paraesthesia—Prednisone—psoriasis	0.000197	0.000639	CcSEcCtD
Trimipramine—Pruritus—Triamcinolone—psoriasis	0.000196	0.000637	CcSEcCtD
Trimipramine—Dizziness—Hydrocortisone—psoriasis	0.000195	0.000632	CcSEcCtD
Trimipramine—Convulsion—Methotrexate—psoriasis	0.000195	0.000631	CcSEcCtD
Trimipramine—Dyspepsia—Prednisone—psoriasis	0.000193	0.000626	CcSEcCtD
Trimipramine—Nausea—Mycophenolate mofetil—psoriasis	0.000192	0.000624	CcSEcCtD
Trimipramine—Decreased appetite—Prednisone—psoriasis	0.000191	0.000619	CcSEcCtD
Trimipramine—Rash—Prednisolone—psoriasis	0.00019	0.000617	CcSEcCtD
Trimipramine—Dermatitis—Prednisolone—psoriasis	0.00019	0.000617	CcSEcCtD
Trimipramine—Fatigue—Prednisone—psoriasis	0.000189	0.000614	CcSEcCtD
Trimipramine—Headache—Prednisolone—psoriasis	0.000189	0.000613	CcSEcCtD
Trimipramine—Discomfort—Methotrexate—psoriasis	0.000189	0.000613	CcSEcCtD
Trimipramine—Constipation—Prednisone—psoriasis	0.000188	0.000609	CcSEcCtD
Trimipramine—Vomiting—Hydrocortisone—psoriasis	0.000187	0.000608	CcSEcCtD
Trimipramine—Rash—Hydrocortisone—psoriasis	0.000186	0.000603	CcSEcCtD
Trimipramine—Dermatitis—Hydrocortisone—psoriasis	0.000186	0.000602	CcSEcCtD
Trimipramine—Confusional state—Methotrexate—psoriasis	0.000185	0.0006	CcSEcCtD
Trimipramine—Headache—Hydrocortisone—psoriasis	0.000185	0.000599	CcSEcCtD
Trimipramine—Dizziness—Triamcinolone—psoriasis	0.000184	0.000596	CcSEcCtD
Trimipramine—Feeling abnormal—Prednisone—psoriasis	0.000181	0.000586	CcSEcCtD
Trimipramine—Asthenia—Dexamethasone—psoriasis	0.000181	0.000586	CcSEcCtD
Trimipramine—Asthenia—Betamethasone—psoriasis	0.000181	0.000586	CcSEcCtD
Trimipramine—Thrombocytopenia—Methotrexate—psoriasis	0.000179	0.000582	CcSEcCtD
Trimipramine—Nausea—Prednisolone—psoriasis	0.000179	0.000582	CcSEcCtD
Trimipramine—Pruritus—Betamethasone—psoriasis	0.000178	0.000578	CcSEcCtD
Trimipramine—Pruritus—Dexamethasone—psoriasis	0.000178	0.000578	CcSEcCtD
Trimipramine—Vomiting—Triamcinolone—psoriasis	0.000176	0.000573	CcSEcCtD
Trimipramine—Nausea—Hydrocortisone—psoriasis	0.000175	0.000568	CcSEcCtD
Trimipramine—Rash—Triamcinolone—psoriasis	0.000175	0.000568	CcSEcCtD
Trimipramine—Dermatitis—Triamcinolone—psoriasis	0.000175	0.000567	CcSEcCtD
Trimipramine—Anorexia—Methotrexate—psoriasis	0.000175	0.000567	CcSEcCtD
Trimipramine—Urticaria—Prednisone—psoriasis	0.000174	0.000565	CcSEcCtD
Trimipramine—Headache—Triamcinolone—psoriasis	0.000174	0.000564	CcSEcCtD
Trimipramine—Abdominal pain—Prednisone—psoriasis	0.000173	0.000563	CcSEcCtD
Trimipramine—Body temperature increased—Prednisone—psoriasis	0.000173	0.000563	CcSEcCtD
Trimipramine—Diarrhoea—Betamethasone—psoriasis	0.000172	0.000559	CcSEcCtD
Trimipramine—Diarrhoea—Dexamethasone—psoriasis	0.000172	0.000559	CcSEcCtD
Trimipramine—Hypotension—Methotrexate—psoriasis	0.000171	0.000556	CcSEcCtD
Trimipramine—Dizziness—Betamethasone—psoriasis	0.000167	0.00054	CcSEcCtD
Trimipramine—Dizziness—Dexamethasone—psoriasis	0.000167	0.00054	CcSEcCtD
Trimipramine—Insomnia—Methotrexate—psoriasis	0.000166	0.000538	CcSEcCtD
Trimipramine—Nausea—Triamcinolone—psoriasis	0.000165	0.000535	CcSEcCtD
Trimipramine—Paraesthesia—Methotrexate—psoriasis	0.000165	0.000534	CcSEcCtD
Trimipramine—Somnolence—Methotrexate—psoriasis	0.000163	0.000529	CcSEcCtD
Trimipramine—Dyspepsia—Methotrexate—psoriasis	0.000161	0.000524	CcSEcCtD
Trimipramine—Vomiting—Dexamethasone—psoriasis	0.00016	0.00052	CcSEcCtD
Trimipramine—Vomiting—Betamethasone—psoriasis	0.00016	0.00052	CcSEcCtD
Trimipramine—Decreased appetite—Methotrexate—psoriasis	0.000159	0.000517	CcSEcCtD
Trimipramine—Rash—Betamethasone—psoriasis	0.000159	0.000515	CcSEcCtD
Trimipramine—Rash—Dexamethasone—psoriasis	0.000159	0.000515	CcSEcCtD
Trimipramine—Dermatitis—Dexamethasone—psoriasis	0.000159	0.000515	CcSEcCtD
Trimipramine—Dermatitis—Betamethasone—psoriasis	0.000159	0.000515	CcSEcCtD
Trimipramine—Fatigue—Methotrexate—psoriasis	0.000158	0.000513	CcSEcCtD
Trimipramine—Headache—Dexamethasone—psoriasis	0.000158	0.000512	CcSEcCtD
Trimipramine—Headache—Betamethasone—psoriasis	0.000158	0.000512	CcSEcCtD
Trimipramine—Asthenia—Prednisone—psoriasis	0.000157	0.000511	CcSEcCtD
Trimipramine—Pruritus—Prednisone—psoriasis	0.000155	0.000503	CcSEcCtD
Trimipramine—Feeling abnormal—Methotrexate—psoriasis	0.000151	0.00049	CcSEcCtD
Trimipramine—Diarrhoea—Prednisone—psoriasis	0.00015	0.000487	CcSEcCtD
Trimipramine—Nausea—Betamethasone—psoriasis	0.00015	0.000485	CcSEcCtD
Trimipramine—Nausea—Dexamethasone—psoriasis	0.00015	0.000485	CcSEcCtD
Trimipramine—Urticaria—Methotrexate—psoriasis	0.000146	0.000472	CcSEcCtD
Trimipramine—Dizziness—Prednisone—psoriasis	0.000145	0.000471	CcSEcCtD
Trimipramine—Abdominal pain—Methotrexate—psoriasis	0.000145	0.00047	CcSEcCtD
Trimipramine—Body temperature increased—Methotrexate—psoriasis	0.000145	0.00047	CcSEcCtD
Trimipramine—Vomiting—Prednisone—psoriasis	0.000139	0.000452	CcSEcCtD
Trimipramine—Rash—Prednisone—psoriasis	0.000138	0.000449	CcSEcCtD
Trimipramine—Dermatitis—Prednisone—psoriasis	0.000138	0.000448	CcSEcCtD
Trimipramine—Headache—Prednisone—psoriasis	0.000137	0.000446	CcSEcCtD
Trimipramine—Asthenia—Methotrexate—psoriasis	0.000131	0.000427	CcSEcCtD
Trimipramine—Nausea—Prednisone—psoriasis	0.00013	0.000423	CcSEcCtD
Trimipramine—Pruritus—Methotrexate—psoriasis	0.00013	0.000421	CcSEcCtD
Trimipramine—Diarrhoea—Methotrexate—psoriasis	0.000125	0.000407	CcSEcCtD
Trimipramine—Dizziness—Methotrexate—psoriasis	0.000121	0.000393	CcSEcCtD
Trimipramine—Vomiting—Methotrexate—psoriasis	0.000117	0.000378	CcSEcCtD
Trimipramine—Rash—Methotrexate—psoriasis	0.000116	0.000375	CcSEcCtD
Trimipramine—Dermatitis—Methotrexate—psoriasis	0.000115	0.000375	CcSEcCtD
Trimipramine—Headache—Methotrexate—psoriasis	0.000115	0.000373	CcSEcCtD
Trimipramine—Nausea—Methotrexate—psoriasis	0.000109	0.000353	CcSEcCtD
Trimipramine—CYP2D6—Metabolism—NDUFA5—psoriasis	3.41e-05	0.000732	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—NDUFA5—psoriasis	3.38e-05	0.000726	CbGpPWpGaD
Trimipramine—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	3.37e-05	0.000722	CbGpPWpGaD
Trimipramine—HTR2A—SIDS Susceptibility Pathways—TNF—psoriasis	3.34e-05	0.000716	CbGpPWpGaD
Trimipramine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	3.3e-05	0.000707	CbGpPWpGaD
Trimipramine—HTR1D—GPCR ligand binding—CXCL8—psoriasis	3.25e-05	0.000697	CbGpPWpGaD
Trimipramine—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	3.21e-05	0.000689	CbGpPWpGaD
Trimipramine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	3.18e-05	0.000683	CbGpPWpGaD
Trimipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	3.17e-05	0.000679	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—CYP2S1—psoriasis	3.15e-05	0.000677	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.15e-05	0.000676	CbGpPWpGaD
Trimipramine—ADRA2B—Hemostasis—NOS2—psoriasis	3.15e-05	0.000675	CbGpPWpGaD
Trimipramine—ADRA2A—G alpha (i) signalling events—CXCL8—psoriasis	3.15e-05	0.000675	CbGpPWpGaD
Trimipramine—HTR1A—SIDS Susceptibility Pathways—IL6—psoriasis	3.12e-05	0.000669	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—CYP2S1—psoriasis	3.08e-05	0.00066	CbGpPWpGaD
Trimipramine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	3.03e-05	0.00065	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—CYP2S1—psoriasis	2.9e-05	0.000622	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—CYP2S1—psoriasis	2.88e-05	0.000617	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CCL20—psoriasis	2.82e-05	0.000604	CbGpPWpGaD
Trimipramine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	2.79e-05	0.000599	CbGpPWpGaD
Trimipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	2.75e-05	0.00059	CbGpPWpGaD
Trimipramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	2.74e-05	0.000588	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CCL20—psoriasis	2.72e-05	0.000584	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CCL20—psoriasis	2.71e-05	0.000581	CbGpPWpGaD
Trimipramine—HTR2A—SIDS Susceptibility Pathways—IL6—psoriasis	2.7e-05	0.000578	CbGpPWpGaD
Trimipramine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	2.69e-05	0.000577	CbGpPWpGaD
Trimipramine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—psoriasis	2.68e-05	0.000576	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CCL20—psoriasis	2.59e-05	0.000556	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR ligand binding—CXCL8—psoriasis	2.51e-05	0.000538	CbGpPWpGaD
Trimipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	2.5e-05	0.000536	CbGpPWpGaD
Trimipramine—DRD2—Circadian rythm related genes—TP53—psoriasis	2.44e-05	0.000524	CbGpPWpGaD
Trimipramine—HTR1A—GPCR ligand binding—CXCL8—psoriasis	2.42e-05	0.00052	CbGpPWpGaD
Trimipramine—HTR2C—GPCR ligand binding—CXCL8—psoriasis	2.41e-05	0.000517	CbGpPWpGaD
Trimipramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	2.4e-05	0.000515	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CCL20—psoriasis	2.39e-05	0.000512	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—NOS2—psoriasis	2.39e-05	0.000512	CbGpPWpGaD
Trimipramine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	2.39e-05	0.000512	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CCL20—psoriasis	2.35e-05	0.000504	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CCL20—psoriasis	2.35e-05	0.000503	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR ligand binding—CXCL8—psoriasis	2.31e-05	0.000495	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CCL20—psoriasis	2.3e-05	0.000494	CbGpPWpGaD
Trimipramine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	2.3e-05	0.000493	CbGpPWpGaD
Trimipramine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	2.3e-05	0.000493	CbGpPWpGaD
Trimipramine—DRD2—Circadian rythm related genes—IL6—psoriasis	2.24e-05	0.00048	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—NDUFA5—psoriasis	2.23e-05	0.000478	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—CARM1—psoriasis	2.17e-05	0.000466	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CCL20—psoriasis	2.14e-05	0.000459	CbGpPWpGaD
Trimipramine—DRD2—GPCR ligand binding—CXCL8—psoriasis	2.13e-05	0.000456	CbGpPWpGaD
Trimipramine—HTR2A—GPCR ligand binding—CXCL8—psoriasis	2.09e-05	0.000449	CbGpPWpGaD
Trimipramine—HRH1—GPCR ligand binding—CXCL8—psoriasis	2.09e-05	0.000448	CbGpPWpGaD
Trimipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	2.09e-05	0.000447	CbGpPWpGaD
Trimipramine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	2.09e-05	0.000447	CbGpPWpGaD
Trimipramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	2.08e-05	0.000446	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR ligand binding—CXCL8—psoriasis	2.05e-05	0.00044	CbGpPWpGaD
Trimipramine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	2.04e-05	0.000438	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—SOCS1—psoriasis	2.01e-05	0.000431	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—TYK2—psoriasis	1.92e-05	0.000411	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR ligand binding—CXCL8—psoriasis	1.9e-05	0.000409	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CYP2S1—psoriasis	1.9e-05	0.000407	CbGpPWpGaD
Trimipramine—HTR1D—GPCR downstream signaling—CXCL8—psoriasis	1.84e-05	0.000394	CbGpPWpGaD
Trimipramine—ADRA2B—Hemostasis—VEGFA—psoriasis	1.82e-05	0.000391	CbGpPWpGaD
Trimipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.79e-05	0.000383	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—CXCL8—psoriasis	1.67e-05	0.000358	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.65e-05	0.000355	CbGpPWpGaD
Trimipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.58e-05	0.000338	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—SOCS1—psoriasis	1.55e-05	0.000333	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—CARM1—psoriasis	1.54e-05	0.00033	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.51e-05	0.000323	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—CARM1—psoriasis	1.5e-05	0.000322	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—SOCS1—psoriasis	1.5e-05	0.000321	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—SOCS1—psoriasis	1.49e-05	0.00032	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—LEP—psoriasis	1.48e-05	0.000318	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—APOE—psoriasis	1.48e-05	0.000318	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—TYK2—psoriasis	1.48e-05	0.000317	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.44e-05	0.000309	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—TYK2—psoriasis	1.43e-05	0.000306	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—SOCS1—psoriasis	1.43e-05	0.000306	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—TYK2—psoriasis	1.42e-05	0.000305	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—CXCL8—psoriasis	1.42e-05	0.000304	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—CARM1—psoriasis	1.42e-05	0.000304	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—CARM1—psoriasis	1.4e-05	0.000301	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—VEGFA—psoriasis	1.38e-05	0.000297	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—NFKBIA—psoriasis	1.38e-05	0.000296	CbGpPWpGaD
Trimipramine—ADRA2B—Hemostasis—TP53—psoriasis	1.38e-05	0.000295	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—CXCL8—psoriasis	1.37e-05	0.000294	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—CXCL8—psoriasis	1.36e-05	0.000292	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—TYK2—psoriasis	1.36e-05	0.000292	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—CAT—psoriasis	1.34e-05	0.000287	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—SOCS1—psoriasis	1.32e-05	0.000282	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.31e-05	0.000282	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—CXCL8—psoriasis	1.3e-05	0.00028	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—SOCS1—psoriasis	1.29e-05	0.000278	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—SOCS1—psoriasis	1.29e-05	0.000277	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—CXCL8—psoriasis	1.29e-05	0.000276	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—SOCS1—psoriasis	1.27e-05	0.000272	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—TYK2—psoriasis	1.25e-05	0.000269	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—CXCL8—psoriasis	1.24e-05	0.000267	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—CXCL8—psoriasis	1.24e-05	0.000265	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—TYK2—psoriasis	1.23e-05	0.000265	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—TYK2—psoriasis	1.23e-05	0.000264	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—TYK2—psoriasis	1.21e-05	0.000259	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—CXCL8—psoriasis	1.2e-05	0.000258	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—CXCL8—psoriasis	1.18e-05	0.000254	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—CXCL8—psoriasis	1.18e-05	0.000254	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—CXCL8—psoriasis	1.18e-05	0.000253	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—SOCS1—psoriasis	1.18e-05	0.000253	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—CXCL8—psoriasis	1.16e-05	0.000248	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—LEP—psoriasis	1.15e-05	0.000246	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—APOE—psoriasis	1.15e-05	0.000246	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—TYK2—psoriasis	1.13e-05	0.000243	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—TYK2—psoriasis	1.12e-05	0.000241	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—LEP—psoriasis	1.11e-05	0.000237	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—APOE—psoriasis	1.11e-05	0.000237	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—APOE—psoriasis	1.1e-05	0.000236	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—LEP—psoriasis	1.1e-05	0.000236	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—CXCL8—psoriasis	1.09e-05	0.000234	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—CXCL8—psoriasis	1.08e-05	0.000231	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—CXCL8—psoriasis	1.07e-05	0.00023	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—CXCL8—psoriasis	1.07e-05	0.00023	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—NFKBIA—psoriasis	1.07e-05	0.000229	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—LEP—psoriasis	1.05e-05	0.000226	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—APOE—psoriasis	1.05e-05	0.000226	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—CXCL8—psoriasis	1.05e-05	0.000226	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—TP53—psoriasis	1.05e-05	0.000224	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—APOE—psoriasis	1.04e-05	0.000223	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—NFKBIA—psoriasis	1.03e-05	0.000221	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—NFKBIA—psoriasis	1.02e-05	0.00022	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—CXCL8—psoriasis	9.85e-06	0.000211	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—NFKBIA—psoriasis	9.81e-06	0.00021	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—CXCL8—psoriasis	9.78e-06	0.00021	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—APOE—psoriasis	9.71e-06	0.000208	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—LEP—psoriasis	9.71e-06	0.000208	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—LEP—psoriasis	9.55e-06	0.000205	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—APOE—psoriasis	9.55e-06	0.000205	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—LEP—psoriasis	9.53e-06	0.000204	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—APOE—psoriasis	9.53e-06	0.000204	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—CAT—psoriasis	9.48e-06	0.000203	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—IL6—psoriasis	9.37e-06	0.000201	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—LEP—psoriasis	9.35e-06	0.000201	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—APOE—psoriasis	9.35e-06	0.000201	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CARM1—psoriasis	9.26e-06	0.000199	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—CAT—psoriasis	9.25e-06	0.000198	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—JUN—psoriasis	9.16e-06	0.000196	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—PPARG—psoriasis	9.05e-06	0.000194	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—NFKBIA—psoriasis	9.05e-06	0.000194	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—NFKBIA—psoriasis	8.9e-06	0.000191	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—NFKBIA—psoriasis	8.88e-06	0.00019	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—NFKB1—psoriasis	8.81e-06	0.000189	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TYK2—psoriasis	8.74e-06	0.000187	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—CAT—psoriasis	8.72e-06	0.000187	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—NFKBIA—psoriasis	8.72e-06	0.000187	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—LEP—psoriasis	8.69e-06	0.000186	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—APOE—psoriasis	8.69e-06	0.000186	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—CAT—psoriasis	8.64e-06	0.000185	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TYK2—psoriasis	8.44e-06	0.000181	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TYK2—psoriasis	8.4e-06	0.00018	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—NFKBIA—psoriasis	8.1e-06	0.000174	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TYK2—psoriasis	8.04e-06	0.000172	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—VEGFA—psoriasis	8e-06	0.000172	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—STAT3—psoriasis	7.92e-06	0.00017	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CXCL8—psoriasis	7.61e-06	0.000163	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TYK2—psoriasis	7.41e-06	0.000159	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—APOE—psoriasis	7.36e-06	0.000158	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CXCL8—psoriasis	7.35e-06	0.000158	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CXCL8—psoriasis	7.31e-06	0.000157	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TYK2—psoriasis	7.29e-06	0.000156	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TYK2—psoriasis	7.27e-06	0.000156	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—IL6—psoriasis	7.24e-06	0.000155	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—APOE—psoriasis	7.19e-06	0.000154	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TYK2—psoriasis	7.14e-06	0.000153	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—JUN—psoriasis	7.08e-06	0.000152	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CXCL8—psoriasis	7e-06	0.00015	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—IL6—psoriasis	6.99e-06	0.00015	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—IL6—psoriasis	6.95e-06	0.000149	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—JUN—psoriasis	6.83e-06	0.000146	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—NFKB1—psoriasis	6.81e-06	0.000146	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—JUN—psoriasis	6.8e-06	0.000146	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—APOE—psoriasis	6.77e-06	0.000145	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—APOE—psoriasis	6.71e-06	0.000144	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—IL6—psoriasis	6.65e-06	0.000143	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TYK2—psoriasis	6.63e-06	0.000142	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—NFKB1—psoriasis	6.57e-06	0.000141	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—NFKB1—psoriasis	6.54e-06	0.00014	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—JUN—psoriasis	6.5e-06	0.00014	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CXCL8—psoriasis	6.45e-06	0.000138	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PPARG—psoriasis	6.41e-06	0.000138	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CXCL8—psoriasis	6.35e-06	0.000136	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CXCL8—psoriasis	6.33e-06	0.000136	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—NFKB1—psoriasis	6.26e-06	0.000134	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PPARG—psoriasis	6.26e-06	0.000134	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CXCL8—psoriasis	6.22e-06	0.000133	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—VEGFA—psoriasis	6.18e-06	0.000133	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—IL6—psoriasis	6.13e-06	0.000132	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—STAT3—psoriasis	6.12e-06	0.000131	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—TP53—psoriasis	6.04e-06	0.00013	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—IL6—psoriasis	6.04e-06	0.000129	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—IL6—psoriasis	6.02e-06	0.000129	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—JUN—psoriasis	6e-06	0.000129	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—VEGFA—psoriasis	5.97e-06	0.000128	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—VEGFA—psoriasis	5.94e-06	0.000127	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—IL6—psoriasis	5.91e-06	0.000127	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—STAT3—psoriasis	5.91e-06	0.000127	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—JUN—psoriasis	5.9e-06	0.000127	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PPARG—psoriasis	5.9e-06	0.000126	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—JUN—psoriasis	5.89e-06	0.000126	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—STAT3—psoriasis	5.88e-06	0.000126	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PPARG—psoriasis	5.85e-06	0.000125	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—JUN—psoriasis	5.78e-06	0.000124	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CXCL8—psoriasis	5.77e-06	0.000124	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—NFKB1—psoriasis	5.77e-06	0.000124	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CAT—psoriasis	5.7e-06	0.000122	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—VEGFA—psoriasis	5.68e-06	0.000122	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—NFKB1—psoriasis	5.68e-06	0.000122	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—NFKB1—psoriasis	5.67e-06	0.000122	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—STAT3—psoriasis	5.63e-06	0.000121	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—NFKB1—psoriasis	5.56e-06	0.000119	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—IL6—psoriasis	5.53e-06	0.000119	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—IL6—psoriasis	5.49e-06	0.000118	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—JUN—psoriasis	5.37e-06	0.000115	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—VEGFA—psoriasis	5.24e-06	0.000112	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—STAT3—psoriasis	5.19e-06	0.000111	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—NFKB1—psoriasis	5.17e-06	0.000111	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—VEGFA—psoriasis	5.16e-06	0.000111	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—VEGFA—psoriasis	5.14e-06	0.00011	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—STAT3—psoriasis	5.1e-06	0.000109	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—STAT3—psoriasis	5.09e-06	0.000109	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—VEGFA—psoriasis	5.05e-06	0.000108	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—STAT3—psoriasis	5e-06	0.000107	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—VEGFA—psoriasis	4.69e-06	0.000101	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TP53—psoriasis	4.67e-06	0.0001	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—STAT3—psoriasis	4.64e-06	9.96e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TP53—psoriasis	4.51e-06	9.67e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TP53—psoriasis	4.49e-06	9.62e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—APOE—psoriasis	4.43e-06	9.5e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TP53—psoriasis	4.29e-06	9.21e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—IL6—psoriasis	4.28e-06	9.17e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—IL6—psoriasis	4.13e-06	8.85e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—IL6—psoriasis	4.11e-06	8.81e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TP53—psoriasis	3.96e-06	8.49e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—IL6—psoriasis	3.93e-06	8.43e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TP53—psoriasis	3.9e-06	8.35e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TP53—psoriasis	3.89e-06	8.34e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PPARG—psoriasis	3.86e-06	8.27e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TP53—psoriasis	3.81e-06	8.18e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IL6—psoriasis	3.62e-06	7.77e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IL6—psoriasis	3.57e-06	7.65e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IL6—psoriasis	3.56e-06	7.63e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TP53—psoriasis	3.54e-06	7.6e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IL6—psoriasis	3.49e-06	7.49e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IL6—psoriasis	3.24e-06	6.96e-05	CbGpPWpGaD
